All positive BPC 157 efficacy data comes from animal studies, most using intraperitoneal or subcutaneous injection at roughly 10 micrograms per kilogram body weight in rodents
By contrast, pre-treatment with SAG at 2.00 mM significantly reduced both levels (Figure 1C,D)
Does it do what its supposed to do, according to science
Injectable GHK-Cu: Systemic and Localized Benefits Injectable GHK-Cu provides more potent, systemic effects and allows for targeted delivery to specific tissues, offering benefits beyond what topical application can achieve
#wellnessjourney | Michael Morales
Co-culture experiments of murine MM cells with bone marrow adipocytes revealed that MM cells upregulate fatty acid transport proteins 1 and 4 (FATP1, FATP4) to acquire PUFAs from neighboring adipocytes